Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended 13D and 13G filings for Better Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-08 5:26 pm Purchase | 2021-10-28 | 13D | Better Therapeutics, Inc. BTTX | Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended | 2,406,719 10.200% | 2,406,719 (New Position) | Filing |